Podcast


Presenter: Adrienne J Lindblad BSP ACPR PharmD G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

Podcast: BS Medicine Episode #489: Mission Slimpossible – Semaglutide for weight loss
0:00

In episode 489, Mike and James invite Adrienne to go over the evidence for weight loss with semaglutide. We find the evidence shows that weight loss is on average roughly 10 kg over the effect of placebo, however this comes at the expense and inconvenience (injection) of the medication and roughly 25% of people (over…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

CFP Podcast: Navigating the landscape of health data, health informatics and digital health: a conversation with Dr Rashaad Bhyat

In this episode of the CFP Podcast, join Deputy Editor Dr Sarah Fraser and Editor Dr Nick Pimlott in a wide-ranging discussion about health data, health informatics and digital health with Dr…
Listen 0.5 credits available

BS Medicine Episode #581: Antibiotics or no antibiotics for acute diverticulitis, that is the question!

In episode 581, Mike and James invite Mike Kolber back to the podcast for the umpteenth time – this time we talk about a topic we haven’t discussed before –…
Listen 0.5 credits available

BS Medicine Episode #580: (A)dressing the Christmas Tree? Therapies for pityriasis rosea

In episode 580, Mike and James invite Jennifer Young to talk about the treatment of pityriasis rosea. Believe it or not there are 2 simple treatments that seem to work…
Listen 0.5 credits available

Presenter(s):

Adrienne J Lindblad BSP ACPR PharmD G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Adrienne J Lindblad BSP ACPR PharmD
  • G. Michael Allan MD CCFP
  • James McCormack BSc(Pharm) PharmD

Spearkers do not have any conflicts of interest to declare.